These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 28403994)

  • 61. Bleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis.
    Lu D; Zhang Q; Liu Q; Wang K; Wang S; Shan Q
    J Interv Card Electrophysiol; 2015 Nov; 44(2):105-11. PubMed ID: 26342485
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation.
    Assiri A; Al-Majzoub O; Kanaan AO; Donovan JL; Silva M
    Clin Ther; 2013 Jul; 35(7):967-984.e2. PubMed ID: 23870607
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort study.
    Maura G; Blotière PO; Bouillon K; Billionnet C; Ricordeau P; Alla F; Zureik M
    Circulation; 2015 Sep; 132(13):1252-60. PubMed ID: 26199338
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management.
    Cheung KS; Leung WK
    World J Gastroenterol; 2017 Mar; 23(11):1954-1963. PubMed ID: 28373761
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The Efficacy and Safety of Anticoagulants in the Treatment of Cirrhotic Portal Vein Thrombosis: A Systematic Review and Meta-Analysis.
    Zhang Z; Zhao Y; Han B; Zhu Z; Sun L; Cui X
    Clin Appl Thromb Hemost; 2022; 28():10760296221104797. PubMed ID: 35656719
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A review of oral anticoagulants in patients with atrial fibrillation.
    Greenspon AJ
    Postgrad Med; 2012 Nov; 124(6):7-16. PubMed ID: 23322134
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A Review of and Recommendations for the Management of Patients With Life-Threatening Dabigatran-Associated Hemorrhage: A Single-Center University Hospital Experience.
    Kumar R; Smith RE; Henry BL
    J Intensive Care Med; 2015 Dec; 30(8):462-72. PubMed ID: 24668159
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Dabigatran use in elderly patients with atrial fibrillation.
    Avgil-Tsadok M; Jackevicius CA; Essebag V; Eisenberg MJ; Rahme E; Behlouli H; Pilote L
    Thromb Haemost; 2016 Jan; 115(1):152-60. PubMed ID: 26354766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness.
    Kahlenberg CA; Richardson SS; Schairer WW; Sculco PK
    J Bone Joint Surg Am; 2018 Aug; 100(16):1366-1372. PubMed ID: 30106817
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A Phase II, double-blind, randomized, parallel group, dose-finding study of the safety and tolerability of darexaban compared with warfarin in patients with non-valvular atrial fibrillation: the oral factor Xa inhibitor for prophylaxis of stroke in atrial fibrillation study 2 (OPAL-2).
    Lip GY; Halperin JL; Petersen P; Rodgers GM; Pall D; Renfurm RW
    J Thromb Haemost; 2015 Aug; 13(8):1405-13. PubMed ID: 26052866
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
    Bai Y; Deng H; Shantsila A; Lip GY
    Stroke; 2017 Apr; 48(4):970-976. PubMed ID: 28213573
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Retrospective comparison of low molecular weight heparin vs. warfarin vs. oral Xa inhibitors for the prevention of recurrent venous thromboembolism in oncology patients: The Re-CLOT study.
    Alzghari SK; Seago SE; Garza JE; Hashimie YF; Baty KA; Evans MF; Shaver C; Herrington JD
    J Oncol Pharm Pract; 2018 Oct; 24(7):494-500. PubMed ID: 28714376
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Novel anticoagulants: bleeding risk and management strategies.
    Abraham NS; Castillo DL
    Curr Opin Gastroenterol; 2013 Nov; 29(6):676-83. PubMed ID: 24100724
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical outcomes with unfractionated heparin or low-molecular-weight heparin as bridging therapy in patients on long-term oral anticoagulants: the REGIMEN registry.
    Spyropoulos AC; Turpie AG; Dunn AS; Spandorfer J; Douketis J; Jacobson A; Frost FJ;
    J Thromb Haemost; 2006 Jun; 4(6):1246-52. PubMed ID: 16706967
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Treatment with inhibitors of new oral direct anticoagulants in patients with severe bleedings or urgent surgical procedures. The new dabigatran antidote: the place of idarucizumab in clinical practice].
    Boda Z
    Orv Hetil; 2016 Mar; 157(12):443-50. PubMed ID: 26971644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation.
    Graham DJ; Reichman ME; Wernecke M; Zhang R; Southworth MR; Levenson M; Sheu TC; Mott K; Goulding MR; Houstoun M; MaCurdy TE; Worrall C; Kelman JA
    Circulation; 2015 Jan; 131(2):157-64. PubMed ID: 25359164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.
    Deitelzweig S; Farmer C; Luo X; Vo L; Li X; Hamilton M; Horblyuk R; Ashaye A
    Curr Med Res Opin; 2017 Sep; 33(9):1583-1594. PubMed ID: 28644048
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Meta-analysis on anticoagulation and prevention of thrombosis and mortality among patients with lung cancer.
    Fuentes HE; Oramas DM; Paz LH; Casanegra AI; Mansfield AS; Tafur AJ
    Thromb Res; 2017 Jun; 154():28-34. PubMed ID: 28402864
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Economic evaluation of prescribing conventional and newer oral anticoagulants in older adults.
    Hasan SS; Kow CS; Curley LE; Baines DL; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2018 Aug; 18(4):371-377. PubMed ID: 29741099
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis.
    Bin Abdulhak AA; Khan AR; Tleyjeh IM; Spertus JA; Sanders SU; Steigerwalt KE; Garbati MA; Bahmaid RA; Wimmer AP
    Europace; 2013 Oct; 15(10):1412-20. PubMed ID: 23954918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.